FDA Inspection 1044979 — Andrew C Sedillo, MD
The FDA completed an inspection of Andrew C Sedillo, MD on February 16, 2018 in Colorado Springs, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 16, 2018
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Colorado Springs, CO (United States)
Additional Details
Clinical Investigator (CI)